{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:57:22Z","timestamp":1781074642228,"version":"3.54.1"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microchim Acta"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00604-026-08068-6","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:14:23Z","timestamp":1778127263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Photonic and nanomaterial-driven optical biosensing strategies for Parkinson\u2019s disease"],"prefix":"10.1007","volume":"193","author":[{"given":"Divya","family":"Soni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3542-2943","authenticated-orcid":false,"given":"Pooja","family":"Ratre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"11","key":"8068_CR1","doi-asserted-by":"publisher","first-page":"8928","DOI":"10.1007\/s12035-024-04128-1","volume":"61","author":"SK Hamidpour","year":"2024","unstructured":"Hamidpour SK, Amiri M, Ketabforoush AHME, Saeedi S, Angaji A, Tavakol S (2024) Unraveling dysregulated cell signaling pathways, genetic and epigenetic mysteries of Parkinson\u2019s disease. Mol Neurobiol 61(11):8928\u20138966","journal-title":"Mol Neurobiol"},{"key":"8068_CR2","doi-asserted-by":"crossref","unstructured":"Kumar L, Malhotra M, Singh AP, Singh AP (2024) Comprehensive review on parkinson\u2019s disease: insights into prevalence, pathophysiology, diagnosis, and multifaceted treatment approaches. J Drug Del Ther 14(6)","DOI":"10.22270\/jddt.v14i6.6637"},{"issue":"6","key":"8068_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19063238","volume":"19","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zhou W, Zhang D (2022) Direct medical costs of Parkinson\u2019s disease in Southern China: a cross-sectional study based on health insurance claims data in Guangzhou City. Int J Environ Res Public Health 19(6):3238","journal-title":"Int J Environ Res Public Health"},{"key":"8068_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102410","author":"A Reddy","year":"2024","unstructured":"Reddy A, Reddy RP, Roghani AK, Garcia RI, Khemka S, Pattoor V et al (2024) Artificial intelligence in Parkinson\u2019s disease: early detection and diagnostic advancements. Ageing Res Rev. https:\/\/doi.org\/10.1016\/j.arr.2024.102410","journal-title":"Ageing Res Rev"},{"issue":"1","key":"8068_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-024-12730-5","volume":"272","author":"A Fanciulli","year":"2025","unstructured":"Fanciulli A, Sixel-D\u00f6ring F, Buhmann C, Krismer F, Hermann W, Winkler C et al (2025) Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson\u2019s disease: guideline \u201cParkinson\u2019s disease\u201d of the German Society of Neurology. J Neurol 272(1):1\u201332","journal-title":"J Neurol"},{"issue":"9","key":"8068_CR6","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.3390\/ijms26094451","volume":"26","author":"M Lucchesi","year":"2025","unstructured":"Lucchesi M, Biso L, Bonaso M, Longoni B, Buchignani B, Battini R et al (2025) Mitochondrial dysfunction in genetic and non-genetic Parkinson\u2019s disease. Int J Mol Sci 26(9):4451","journal-title":"Int J Mol Sci"},{"key":"8068_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/febs.70140","volume-title":"In vivo and in silico models of Drosophila for Parkinson\u2019s disease","author":"MF Cesur","year":"2025","unstructured":"Cesur MF, Strazdins R, Sarkar S, \u00c7ak\u0131r T (2025) In vivo and in silico models of Drosophila for Parkinson\u2019s disease. FEBS J"},{"issue":"3","key":"8068_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V (2023) Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14(3):176","journal-title":"Cell Death Dis"},{"issue":"5","key":"8068_CR9","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/joim.13541","volume":"292","author":"M Hariz","year":"2022","unstructured":"Hariz M, Blomstedt P (2022) Deep brain stimulation for Parkinson\u2019s disease. J Intern Med 292(5):764\u2013778","journal-title":"J Intern Med"},{"issue":"1","key":"8068_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s43440-022-00445-1","volume":"75","author":"M Kumar","year":"2023","unstructured":"Kumar M, Nguyen TN, Kaur J, Singh TG, Soni D, Singh R et al (2023) Opportunities and challenges in application of artificial intelligence in pharmacology. Pharmacol Rep 75(1):3\u201318","journal-title":"Pharmacol Rep"},{"issue":"5","key":"8068_CR11","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/bcpt.14003","volume":"134","author":"N Ghosh","year":"2024","unstructured":"Ghosh N, Sinha K, Sil PC (2024) A review on the new age methodologies for early detection of Alzheimer\u2019s and Parkinson\u2019s disease. Basic Clin Pharmacol Toxicol 134(5):602\u2013613","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"8068_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2025.104537","author":"K Sharma","year":"2025","unstructured":"Sharma K, Shanbhog M, Singh K (2025) Machine learning in neuroimaging and computational pathophysiology of Parkinson\u2019s disease: a comprehensive review and meta-analysis. Asian J Psychiatr. https:\/\/doi.org\/10.1016\/j.ajp.2025.104537","journal-title":"Asian J Psychiatr"},{"issue":"2","key":"8068_CR13","doi-asserted-by":"publisher","first-page":"eadi8287","DOI":"10.1126\/sciadv.adi8287","volume":"10","author":"Q Wang","year":"2024","unstructured":"Wang Q, Wang M, Choi I, Sarrafha L, Liang M, Ho L et al (2024) Molecular profiling of human substantia nigra identifies diverse neuron types associated with vulnerability in Parkinson\u2019s disease. Sci Adv 10(2):eadi8287","journal-title":"Sci Adv"},{"issue":"6","key":"8068_CR14","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1046\/j.1471-4159.1999.0732586.x","volume":"73","author":"NG Kholodilov","year":"1999","unstructured":"Kholodilov NG, Neystat M, Tinmarla FO, Steven EL, Larsen KE, Sulzer D et al (1999) Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury. J Neurochem 73(6):2586\u20132599","journal-title":"J Neurochem"},{"issue":"2","key":"8068_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0304-3940(99)00740-5","volume":"275","author":"NG Kholodilov","year":"1999","unstructured":"Kholodilov NG, Oo TF, Burke RE (1999) Synuclein expression is decreased in rat substantia nigra following induction of apoptosis by intrastriatal 6-hydroxydopamine. Neurosci Lett 275(2):105\u2013108","journal-title":"Neurosci Lett"},{"key":"8068_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105432","volume":"111","author":"AJ Espay","year":"2023","unstructured":"Espay AJ, McFarthing K (2023) Alpha-synuclein and the Parkinson\u2019s disease drug pipeline. Parkinsonism Relat Disord 111:105432","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"8068_CR17","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1007\/s10787-024-01510-2","volume":"32","author":"D Soni","year":"2024","unstructured":"Soni D, Upadhayay S, Dhureja M, Arthur R, Kumar P (2024) Crosstalk between gut\u2013brain axis: unveiling the mysteries of gut ROS in progression of Parkinson\u2019s disease. Inflammopharmacology 32(5):2921\u20132941","journal-title":"Inflammopharmacology"},{"issue":"9","key":"8068_CR18","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1080\/87559129.2024.2337766","volume":"40","author":"D Soni","year":"2024","unstructured":"Soni D, Jamwal S, Chawla R, Singh SK, Singh D, Singh TG et al (2024) Nutraceuticals unveiled a multifaceted neuroprotective mechanisms for Parkinson\u2019s disease: elixir for the brain. Food Rev Intl 40(9):3079\u20133102","journal-title":"Food Rev Intl"},{"issue":"4","key":"8068_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s43440-022-00390-z","volume":"74","author":"D Soni","year":"2022","unstructured":"Soni D, Kumar P (2022) GSK-3\u03b2-mediated regulation of Nrf2\/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders. Pharmacol Rep 74(4):557\u2013569","journal-title":"Pharmacol Rep"},{"issue":"4","key":"8068_CR20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1162\/netn_a_00208","volume":"5","author":"P Putra","year":"2021","unstructured":"Putra P, Thompson TB, Chaggar P, Goriely A (2021) Braiding Braak and Braak: staging patterns and model selection in network neurodegeneration. Netw Neurosci 5(4):929\u2013956","journal-title":"Netw Neurosci"},{"key":"8068_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105601","volume":"163","author":"H Chen","year":"2022","unstructured":"Chen H, Wang K, Scheperjans F, Killinger B (2022) Environmental triggers of Parkinson\u2019s disease\u2013implications of the Braak and dual-hit hypotheses. Neurobiol Dis 163:105601","journal-title":"Neurobiol Dis"},{"issue":"10423","key":"8068_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH (2024) The pathogenesis of Parkinson\u2019s disease. Lancet 403(10423):293\u2013304","journal-title":"Lancet"},{"issue":"3","key":"8068_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/genes13030471","volume":"13","author":"F Jia","year":"2022","unstructured":"Jia F, Fellner A, Kumar KR (2022) Monogenic Parkinson\u2019s disease: genotype, phenotype, pathophysiology, and genetic testing. Genes 13(3):471","journal-title":"Genes"},{"issue":"1","key":"8068_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mdc3.12568","volume":"5","author":"MM Abbas","year":"2018","unstructured":"Abbas MM, Xu Z, Tan LC (2018) Epidemiology of Parkinson\u2019s disease\u2014East versus West. Mov Disord Clin Pract 5(1):14\u201328","journal-title":"Mov Disord Clin Pract"},{"issue":"12","key":"8068_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.168144","volume":"435","author":"C Themistokleous","year":"2023","unstructured":"Themistokleous C, Bagnoli E, Parulekar R, Muqit MM (2023) Role of autophagy pathway in Parkinson\u2019s disease and related genetic neurological disorders. J Mol Biol 435(12):168144","journal-title":"J Mol Biol"},{"key":"8068_CR26","doi-asserted-by":"crossref","unstructured":"Yahalom G, Greenbaum L, Israeli-Korn S, Fay-Karmon T, Livneh V, Ruskey JA et al. (2019) Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson\u2019s disease: risk estimates and genotype-phenotype correlations. Parkinsonism Rel Disorders 62:179\u201384","DOI":"10.1016\/j.parkreldis.2018.12.014"},{"key":"8068_CR27","unstructured":"Carr J, Bardien S (2012) 12 LRRK2-associated Parkinson\u2019s disease. Parkinson\u2019s Disease 143"},{"key":"8068_CR28","doi-asserted-by":"crossref","unstructured":"Wang S, Liu Z, Ye T, Mabrouk OS, Maltbie T, Aasly J et al. (2017) Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers. Acta neuropathologica communications 5:1\u201313","DOI":"10.1186\/s40478-017-0492-y"},{"issue":"1","key":"8068_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-020-00138-7","volume":"6","author":"S Wang","year":"2020","unstructured":"Wang S, Kelly K, Brotchie JM, Koprich JB, West AB (2020) Exosome markers of LRRK2 kinase inhibition. NPJ Parkinsons Dis 6(1):32","journal-title":"NPJ Parkinsons Dis"},{"key":"8068_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177523","volume":"998","author":"D Soni","year":"2025","unstructured":"Soni D, Garg Y, Upadhayay S, Bhatia A, Basir B, Singh SK et al (2025) Auranofin-loaded chitosan-lipid hybrid nanoparticle protects against rotenone model of Parkinson\u2019s disease via modulation of GSK-3\u03b2\/Nrf2\/HO-1 signaling. Eur J Pharmacol 998:177523","journal-title":"Eur J Pharmacol"},{"issue":"23","key":"8068_CR31","doi-asserted-by":"publisher","first-page":"7023","DOI":"10.1113\/JP273839","volume":"595","author":"DF Wilson","year":"2017","unstructured":"Wilson DF (2017) Oxidative phosphorylation: regulation and role in cellular and tissue metabolism. J Physiol 595(23):7023\u20137038","journal-title":"J Physiol"},{"issue":"1","key":"8068_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/13510002.2022.2046423","volume":"27","author":"B Zhang","year":"2022","unstructured":"Zhang B, Pan C, Feng C, Yan C, Yu Y, Chen Z et al (2022) Role of mitochondrial reactive oxygen species in homeostasis regulation. Redox Rep 27(1):45\u201352","journal-title":"Redox Rep"},{"issue":"11","key":"8068_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22(11):657\u2013673","journal-title":"Nat Rev Immunol"},{"key":"8068_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113315","volume":"330","author":"A Haque","year":"2020","unstructured":"Haque A, Samantaray S, Knaryan VH, Capone M, Hossain A, Matzelle D et al (2020) Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson\u2019s disease. Exp Neurol 330:113315","journal-title":"Exp Neurol"},{"key":"8068_CR35","doi-asserted-by":"crossref","unstructured":"Zaman V, Shields DC, Shams R, Drasites KP, Matzelle D, Haque A et al. (2021) Cellular and molecular pathophysiology in the progression of Parkinson\u2019s disease. Metab Brain Disease 36:815\u201327","DOI":"10.1007\/s11011-021-00689-5"},{"issue":"3","key":"8068_CR36","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/fcp.12968","volume":"38","author":"NG Yedke","year":"2024","unstructured":"Yedke NG, Soni D, Kumar P (2024) Effect of Bacille\u2010Calmette\u2010Guerin vaccine against rotenone\u2010induced Parkinson\u2019s disease: role of neuroinflammation and neurotransmitters. Fundam Clin Pharmacol 38(3):538\u2013549","journal-title":"Fundam Clin Pharmacol"},{"issue":"12","key":"8068_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.14451","volume":"46","author":"M Mundkar","year":"2022","unstructured":"Mundkar M, Bijalwan A, Soni D, Kumar P (2022) Neuroprotective potential of Moringa oleifera mediated by NF\u2010kB\/Nrf2\/HO\u20101 signaling pathway: a review. J Food Biochem 46(12):e14451","journal-title":"J Food Biochem"},{"issue":"6","key":"8068_CR38","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00702-024-02747-5","volume":"131","author":"N Hattori","year":"2024","unstructured":"Hattori N, Funayama M, Imai Y, Hatano T (2024) Pathogenesis of Parkinson\u2019s disease: from hints from monogenic familial PD to biomarkers. J Neural Transm 131(6):709\u2013719","journal-title":"J Neural Transm"},{"issue":"1","key":"8068_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00357-0","volume":"8","author":"P Magalh\u00e3es","year":"2022","unstructured":"Magalh\u00e3es P, Lashuel HA (2022) Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson\u2019s disease and other synucleinopathies. NPJ Parkinsons Dis 8(1):93","journal-title":"NPJ Parkinsons Dis"},{"key":"8068_CR40","doi-asserted-by":"crossref","unstructured":"Atik A, Stewart T, Zhang J (2016) Alpha\u2010synuclein as a biomarker for Parkinson\u2019s disease. Brain Pathol 26(3):410\u20138","DOI":"10.1111\/bpa.12370"},{"issue":"10","key":"8068_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25105307","volume":"25","author":"KY Kim","year":"2024","unstructured":"Kim KY, Shin KY, Chang K-A (2024) Potential exosome biomarkers for Parkinson\u2019s disease diagnosis: a systematic review and meta-analysis. Int J Mol Sci 25(10):5307","journal-title":"Int J Mol Sci"},{"key":"8068_CR42","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neuroscience.2019.05.015","volume":"413","author":"X Si","year":"2019","unstructured":"Si X, Tian J, Chen Y, Yan Y, Pu J, Zhang B (2019) Central nervous system-derived exosomal alpha-synuclein in serum may be a biomarker in Parkinson\u2019s disease. Neuroscience 413:308\u2013316","journal-title":"Neuroscience"},{"key":"8068_CR43","doi-asserted-by":"crossref","unstructured":"Zubelzu M, Morera-Herreras T, Irastorza G, G\u00f3mez-Esteban JC, Murueta-Goyena A (2022) Plasma and serum alpha-synuclein as a biomarker in Parkinson\u2019s disease: a meta-analysis. Parkinsonism Rel Disorders 99:107\u201315","DOI":"10.1016\/j.parkreldis.2022.06.001"},{"issue":"21","key":"8068_CR44","doi-asserted-by":"publisher","first-page":"e2417","DOI":"10.1212\/WNL.0000000000201199","volume":"99","author":"N Majbour","year":"2022","unstructured":"Majbour N, Aasly J, Abdi I, Ghanem S, Erskine D, Van De Berg W et al (2022) Disease-associated \u03b1-synuclein aggregates as biomarkers of Parkinson disease clinical stage. Neurology 99(21):e2417\u2013e2427","journal-title":"Neurology"},{"issue":"3","key":"8068_CR45","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s13760-023-02452-2","volume":"124","author":"H Shu","year":"2024","unstructured":"Shu H, Zhang P, Gu L (2024) Alpha-synuclein in peripheral body fluid as a biomarker for Parkinson\u2019s disease. Acta Neurol Belg 124(3):831\u2013842","journal-title":"Acta Neurol Belg"},{"key":"8068_CR46","doi-asserted-by":"crossref","unstructured":"Yan S, Jiang C, Janzen A, Barber TR, Seger A, Sommerauer M et al. (2024) Neuronally derived extracellular vesicle \u03b1-synuclein as a serum biomarker for individuals at risk of developing Parkinson disease. JAMA Neurol 81(1):59\u201368.","DOI":"10.1001\/jamaneurol.2023.4398"},{"key":"8068_CR47","doi-asserted-by":"crossref","unstructured":"Wang Z, Becker K, Donadio V, Siedlak S, Yuan J, Rezaee M et al. (2021) Skin \u03b1-synuclein aggregation seeding activity as a novel biomarker for Parkinson disease. JAMA Neurol 78(1):30\u201340","DOI":"10.1001\/jamaneurol.2020.3311"},{"key":"8068_CR48","doi-asserted-by":"crossref","unstructured":"Surguchov A (2021) Biomarkers in Parkinson\u2019s disease. Neurodegenerative diseases biomarkers: Towards translating research to clinical practice. Springer 155\u201380.","DOI":"10.1007\/978-1-0716-1712-0_7"},{"issue":"3","key":"8068_CR49","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3390\/ijms23031519","volume":"23","author":"M Suzuki","year":"2022","unstructured":"Suzuki M, Sango K, Nagai Y (2022) Roles of \u03b1-Synuclein and disease-associated factors in Drosophila models of Parkinson\u2019s disease. Int J Mol Sci 23(3):1519","journal-title":"Int J Mol Sci"},{"key":"8068_CR50","unstructured":"Wilson E (2025) Multi-omics characterization of the snca-a53t mutation in parkinson\u2019s disease"},{"issue":"9","key":"8068_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4236\/ajac.2024.159018","volume":"15","author":"OA Olahanmi","year":"2024","unstructured":"Olahanmi OA (2024) The application of analytical techniques to alpha-synuclein in Parkinson\u2019s disease. Am J Anal Chem 15(9):269\u2013285","journal-title":"Am J Anal Chem"},{"key":"8068_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2022.107959","volume":"183","author":"MD Kumar","year":"2022","unstructured":"Kumar MD, Karthikeyan M, Sharma N, Raju V, Vatsalarani J, Kalivendi SV et al (2022) Molecular imprinting synthetic receptor based sensor for determination of Parkinson\u2019s disease biomarker DJ-1. Microchem J 183:107959","journal-title":"Microchem J"},{"issue":"2","key":"8068_CR53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10522-025-10227-w","volume":"26","author":"QA Alshammari","year":"2025","unstructured":"Alshammari QA (2025) Redox modulatory role of DJ-1 in Parkinson\u2019s disease. Biogerontology 26(2):81","journal-title":"Biogerontology"},{"issue":"1","key":"8068_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02136-9","volume":"23","author":"L Lv","year":"2025","unstructured":"Lv L, Zhang H, Tan J, Wang C (2025) Neuroprotective role and mechanistic insights of DJ-1 dimerization in Parkinson\u2019s disease. Cell Commun Signal 23(1):129","journal-title":"Cell Commun Signal"},{"issue":"1","key":"8068_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02776-z","volume":"20","author":"F Lind-Holm Mogensen","year":"2023","unstructured":"Lind-Holm Mogensen F, Scafidi A, Poli A, Michelucci A (2023) PARK7\/DJ-1 in microglia: implications in Parkinson\u2019s disease and relevance as a therapeutic target. J Neuroinflammation 20(1):95","journal-title":"J Neuroinflammation"},{"key":"8068_CR56","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fnagi.2014.00102","volume":"6","author":"W-Y Kang","year":"2014","unstructured":"Kang W-Y, Yang Q, Jiang X-F, Chen W, Zhang L-Y, Wang X-Y et al (2014) Salivary DJ-1 could be an indicator of Parkinson\u2019s disease progression. Frontiers in aging neuroscience 6:102","journal-title":"Frontiers in aging neuroscience"},{"issue":"2","key":"8068_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020404","volume":"10","author":"U Kern","year":"2021","unstructured":"Kern U, Fr\u00f6hlich K, Bedacht J, Schmidt N, Biniossek ML, Gensch N et al (2021) Impact of DJ-1 and helix 8 on the proteome and degradome of neuron-like cells. Cells 10(2):404","journal-title":"Cells"},{"key":"8068_CR58","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fnagi.2017.00232","volume":"9","author":"Y Chen","year":"2017","unstructured":"Chen Y, Gao C, Sun Q, Pan H, Huang P, Ding J et al (2017) MicroRNA-4639 is a regulator of DJ-1 expression and a potential early diagnostic marker for Parkinson\u2019s disease. Front Aging Neurosci 9:232","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"8068_CR59","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/AOMD.AOMD_23_19","volume":"2","author":"R Shree","year":"2019","unstructured":"Shree R, Mulagala M, Mehta S, Sood A, Modi M, Goyal MK et al (2019) Role of DJ-1 and Apo A1 as biomarkers in Parkinson\u2019s disease: an observational case-control study. Annals Move Disorders 2(3):109\u2013114","journal-title":"Annals Move Disorders"},{"issue":"11","key":"8068_CR60","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1080\/10715762.2024.2430536","volume":"58","author":"K Matsuda","year":"2024","unstructured":"Matsuda K, Mita Y, Saigoh K, Saito Y, Noguchi N (2024) Modifications of DJ-1 in which pI shifts to acidic in red blood cells a potential biomarker for Parkinson\u2019s disease at early stages. Free Radic Res 58(11):748\u2013757","journal-title":"Free Radic Res"},{"key":"8068_CR61","doi-asserted-by":"crossref","unstructured":"Liu T-W, Chen C-M, Chang K-H (2022) Biomarker of neuroinflammation in Parkinson\u2019s disease. Int J Mol Sci 23(8):4148","DOI":"10.3390\/ijms23084148"},{"issue":"1","key":"8068_CR62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41531-023-00449-5","volume":"9","author":"Y Qu","year":"2023","unstructured":"Qu Y, Li J, Qin Q, Wang D, Zhao J, An K et al (2023) A systematic review and meta-analysis of inflammatory biomarkers in Parkinson\u2019s disease. npj Parkinson\u2019s Disease 9(1):18","journal-title":"npj Parkinson\u2019s Disease"},{"issue":"1","key":"8068_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00515-1","volume":"17","author":"KA Staats","year":"2022","unstructured":"Staats KA, Borchelt DR, Tansey MG, Wymer J (2022) Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis. Mol Neurodegener 17(1):11","journal-title":"Mol Neurodegener"},{"issue":"s1","key":"8068_CR64","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.3233\/JPD-223277","volume":"12","author":"M Zimmermann","year":"2022","unstructured":"Zimmermann M, Brockmann K (2022) Blood and cerebrospinal fluid biomarkers of inflammation in Parkinson\u2019s disease. J Parkinsons Dis 12(s1):S183\u2013S200","journal-title":"J Parkinsons Dis"},{"key":"8068_CR65","doi-asserted-by":"crossref","unstructured":"Santaella A, Kuiperij HB, van Rumund A, Esselink RA, van Gool AJ, Bloem BR et al. (2020) Inflammation biomarker discovery in Parkinson\u2019s disease and atypical parkinsonisms. BMC Neurology 20:1\u20138","DOI":"10.1186\/s12883-020-1608-8"},{"issue":"1","key":"8068_CR66","doi-asserted-by":"publisher","DOI":"10.62641\/aep.v53i1.1779","volume":"53","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Fu Q, Guo X, He H, Yang G (2025) Potential biomarkers and treatment of neuroinflammation in Parkinson\u2019s disease. Actas Esp Psiquiatr 53(1):181","journal-title":"Actas Esp Psiquiatr"},{"issue":"32","key":"8068_CR67","doi-asserted-by":"publisher","first-page":"19433","DOI":"10.1074\/jbc.M115.660001","volume":"290","author":"JP Daher","year":"2015","unstructured":"Daher JP, Abdelmotilib HA, Hu X, Volpicelli-Daley LA, Moehle MS, Fraser KB et al (2015) Leucine-rich repeat kinase 2 (LRRK2) pharmacological inhibition abates \u03b1-synuclein gene-induced neurodegeneration. J Biol Chem 290(32):19433\u201319444","journal-title":"J Biol Chem"},{"key":"8068_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0344-2","volume":"14","author":"DC Berwick","year":"2019","unstructured":"Berwick DC, Heaton GR, Azeggagh S, Harvey K (2019) LRRK2 biology from structure to dysfunction: research progresses, but the themes remain the same. Mol Neurodegener 14:1\u201322","journal-title":"Mol Neurodegener"},{"issue":"4","key":"8068_CR69","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/mds.28890","volume":"37","author":"CH Lin","year":"2022","unstructured":"Lin CH, Lin HY, Ho EP, Ke YC, Cheng MF, Shiue CY et al (2022) Mild chronic colitis triggers parkinsonism in LRRK2 mutant mice through activating TNF-\u03b1 pathway. Mov Disord 37(4):745\u2013757","journal-title":"Mov Disord"},{"issue":"4","key":"8068_CR70","doi-asserted-by":"publisher","first-page":"e200132","DOI":"10.1212\/NXI.0000000000200132","volume":"10","author":"CC Pedersen","year":"2023","unstructured":"Pedersen CC, Ushakova A, Skogseth RE, Alves G, Tysnes O-B, Aarsland D et al (2023) Inflammatory biomarkers in newly diagnosed patients with Parkinson disease and related neurodegenerative disorders. Neurol Neuroimmunol Neuroinflamm 10(4):e200132","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"8068_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00625","volume":"12","author":"AE Roser","year":"2018","unstructured":"Roser AE, Caldi Gomes L, Sch\u00fcnemann J, Maass F, Lingor P (2018) Circulating miRNAs as diagnostic biomarkers for Parkinson\u2019s disease. Front Neurosci 12:625","journal-title":"Front Neurosci"},{"key":"8068_CR72","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.parkreldis.2015.11.014","volume":"22","author":"H Ding","year":"2016","unstructured":"Ding H, Huang Z, Chen M, Wang C, Chen X, Chen J et al (2016) Identification of a panel of five serum miRNAs as a biomarker for Parkinson\u2019s disease. Parkinsonism Relat Disord 22:68\u201373","journal-title":"Parkinsonism Relat Disord"},{"key":"8068_CR73","doi-asserted-by":"publisher","first-page":"738530","DOI":"10.3389\/fneur.2021.738530","volume":"12","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Chen J, Sun Y, Li F, Wei L, Sun W et al (2021) Profiling of differentially expressed MicroRNAs in saliva of Parkinson\u2019s disease patients. Front Neurol 12:738530","journal-title":"Front Neurol"},{"key":"8068_CR74","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neulet.2017.02.045","volume":"644","author":"X-Y Cao","year":"2017","unstructured":"Cao X-Y, Lu J-M, Zhao Z-Q, Li M-C, Lu T, An X-S et al (2017) MicroRNA biomarkers of Parkinson\u2019s disease in serum exosome-like microvesicles. Neurosci Lett 644:94\u201399","journal-title":"Neurosci Lett"},{"issue":"12","key":"8068_CR75","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.3390\/ijms18122698","volume":"18","author":"L Leggio","year":"2017","unstructured":"Leggio L, Vivarelli S, L\u2019Episcopo F, Tirolo C, Caniglia S, Testa N et al (2017) microRNAs in Parkinson\u2019s disease: from pathogenesis to novel diagnostic and therapeutic approaches. Int J Mol Sci 18(12):2698","journal-title":"Int J Mol Sci"},{"issue":"7","key":"8068_CR76","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.nrleng.2024.07.004","volume":"39","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang Y, Yao Y, Zhang G, Zhang Y, Gao S (2024) Circulating microRNAs as potential biomarkers for the diagnosis of Parkinson\u2019s disease: a meta-analysis. Neurolog\u00eda (English Edition) 39(7):573\u2013583","journal-title":"Neurolog\u00eda (English Edition)"},{"issue":"17","key":"8068_CR77","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.2217\/bmm-2019-0315","volume":"13","author":"SF Hamm-Alvarez","year":"2019","unstructured":"Hamm-Alvarez SF, Janga SR, Edman MC, Feigenbaum D, Freire D, Mack WJ et al (2019) Levels of oligomeric \u03b1-synuclein in reflex tears distinguish Parkinson\u2019s disease patients from healthy controls. Biomarkers Med 13(17):1447\u201357","journal-title":"Biomarkers Med"},{"key":"8068_CR78","doi-asserted-by":"crossref","unstructured":"Baumann CR (2012) Epidemiology, diagnosis and differential diagnosis in Parkinson\u2019s disease tremor. Parkinsonism Related disorders 18:S90-S2","DOI":"10.1016\/S1353-8020(11)70029-3"},{"issue":"19","key":"8068_CR79","doi-asserted-by":"publisher","first-page":"e2429","DOI":"10.1212\/WNL.0000000000011852","volume":"96","author":"R Kim","year":"2021","unstructured":"Kim R, Park S, Yoo D, Jun J-S, Jeon B (2021) Association of physical activity and APOE genotype with longitudinal cognitive change in early Parkinson disease. Neurology 96(19):e2429\u2013e2437","journal-title":"Neurology"},{"issue":"5","key":"8068_CR80","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/mds.27989","volume":"35","author":"T Simuni","year":"2020","unstructured":"Simuni T, Brumm MC, Uribe L, Caspell\u2010Garcia C, Coffey CS, Siderowf A et al (2020) Clinical and dopamine transporter imaging characteristics of leucine rich repeat kinase 2 (LRRK2) and glucosylceramidase beta (GBA) Parkinson\u2019s disease participants in the Parkinson\u2019s progression markers initiative: a cross\u2010sectional study. Mov Disord 35(5):833\u2013844","journal-title":"Mov Disord"},{"issue":"1","key":"8068_CR81","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1136\/jnnp-2017-316213","volume":"89","author":"T Simuni","year":"2018","unstructured":"Simuni T, Caspell-Garcia C, Coffey CS, Weintraub D, Mollenhauer B, Lasch S et al (2018) Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson\u2019s disease: the PPMI cohort. J Neurol Neurosurg Psychiatry 89(1):78\u201388","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8068_CR82","unstructured":"ClinicalTrials.gov (2026) National Library of Medicine, United States of America. https:\/\/clinicaltrials.gov\/search?cond=Parkinson%20Disease&term=biomarkers&viewType=CardAccessed. Accessed 26 June 2025."},{"key":"8068_CR83","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/bs.pbr.2020.01.003","volume":"252","author":"E Schaeffer","year":"2020","unstructured":"Schaeffer E, Postuma RB, Berg D (2020) Prodromal PD: A new nosological entity. Prog Brain Res 252:331\u201356","journal-title":"Prog Brain Res"},{"key":"8068_CR84","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2022.04.020","volume":"99","author":"SD Black","year":"2022","unstructured":"Black SD, Del Bene VA, Celka AS, Guthrie B, Martin RC, Olson J et al (2022) Nascent visual artistic expression following right hemisphere subthalamic nucleus deep brain stimulation for Parkinson\u2019s disease. Parkinsonism Relat Disord 99:47\u201350","journal-title":"Parkinsonism Relat Disord"},{"key":"8068_CR85","doi-asserted-by":"crossref","unstructured":"Mej\u00eda M, Rodr\u00edguez-Leyva I, Cort\u00e9s-Enr\u00edquez F, Chi-Ahumada E, Portales-P\u00e9rez DP, Mac\u00edas-Islas MA et al. (2019) Low levels of alpha-synuclein in peripheral tissues are related to clinical relapse in relapsing-remitting multiple sclerosis: a pilot cross-sectional study. J Neurol Sci 396:87\u201393","DOI":"10.1016\/j.jns.2018.11.003"},{"issue":"1","key":"8068_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87031-2","volume":"11","author":"O Bichsel","year":"2021","unstructured":"Bichsel O, Stieglitz LH, Oertel MF, Baumann CR, Gassert R, Imbach LL (2021) Deep brain electrical neurofeedback allows Parkinson patients to control pathological oscillations and quicken movements. Sci Rep 11(1):7973","journal-title":"Sci Rep"},{"issue":"1","key":"8068_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43096-9","volume":"13","author":"D Gu\u00e9vremont","year":"2023","unstructured":"Gu\u00e9vremont D, Roy J, Cutfield NJ, Williams JM (2023) MicroRNAs in Parkinson\u2019s disease: a systematic review and diagnostic accuracy meta-analysis. Sci Rep 13(1):16272","journal-title":"Sci Rep"},{"key":"8068_CR88","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Garc\u00eda J, Muro-Reche P, Orenes-Pi\u00f1ero E (2025) Gut microbiota and microRNAs as biomarkers in Parkinson\u2019s disease: early identification, diagnostic and potential treatments. Mol Cell Biochem 1\u201314","DOI":"10.1007\/s11010-025-05271-6"},{"issue":"10","key":"8068_CR89","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1001\/jamaneurol.2021.1312","volume":"78","author":"T Mitchell","year":"2021","unstructured":"Mitchell T, Leh\u00e9ricy S, Chiu SY, Strafella AP, Stoessl AJ, Vaillancourt DE (2021) Emerging neuroimaging biomarkers across disease stage in Parkinson disease: a review. JAMA Neurol 78(10):1262\u20131272","journal-title":"JAMA Neurol"},{"key":"8068_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120220","volume":"436","author":"H Golan","year":"2022","unstructured":"Golan H, Volkov O, Shalom E (2022) Nuclear imaging in Parkinson\u2019s disease: the past, the present, and the future. J Neurol Sci 436:120220","journal-title":"J Neurol Sci"},{"issue":"4","key":"8068_CR91","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/jnc.15516","volume":"159","author":"NS Bidesi","year":"2021","unstructured":"Bidesi NS, Vang Andersen I, Windhorst AD, Shalgunov V, Herth MM (2021) The role of neuroimaging in Parkinson\u2019s disease. J Neurochem 159(4):660\u2013689","journal-title":"J Neurochem"},{"issue":"4","key":"8068_CR92","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41582-022-00618-9","volume":"18","author":"J-Y Lee","year":"2022","unstructured":"Lee J-Y, Martin-Bastida A, Murueta-Goyena A, Gabilondo I, Cuenca N, Piccini P et al (2022) Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease. Nat Rev Neurol 18(4):203\u2013220","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"8068_CR93","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/ene.14613","volume":"28","author":"WC Zhou","year":"2021","unstructured":"Zhou WC, Tao JX, Li J (2021) Optical coherence tomography measurements as potential imaging biomarkers for Parkinson\u2019s disease: a systematic review and meta\u2010analysis. Eur J Neurol 28(3):763\u2013774","journal-title":"Eur J Neurol"},{"issue":"6","key":"8068_CR94","doi-asserted-by":"publisher","first-page":"371","DOI":"10.62347\/AICM8774","volume":"14","author":"J Gujral","year":"2024","unstructured":"Gujral J, Gandhi OH, Singh SB, Ahmed M, Ayubcha C, Werner TJ et al (2024) PET, SPECT, and MRI imaging for evaluation of Parkinson\u2019s disease. Am J Nucl Med Mol Imaging 14(6):371","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"3","key":"8068_CR95","doi-asserted-by":"publisher","DOI":"10.1007\/s12668-025-02143-7","volume":"15","author":"T Mallick","year":"2025","unstructured":"Mallick T, Joshi RK, Mishra R (2025) Nanoparticle-based biosensors for pathogen detection: current updates and future prospects. BioNanoScience 15(3):523","journal-title":"BioNanoScience"},{"issue":"48","key":"8068_CR96","doi-asserted-by":"publisher","first-page":"2403560","DOI":"10.1002\/smll.202403560","volume":"20","author":"JW Yang","year":"2024","unstructured":"Yang JW, Khorsandi D, Trabucco L, Ahmed M, Khademhosseini A, Dokmeci MR et al (2024) Liver-on-a-chip integrated with label-free optical biosensors for rapid and continuous monitoring of drug-induced toxicity. Small 20(48):2403560","journal-title":"Small"},{"key":"8068_CR97","doi-asserted-by":"crossref","unstructured":"Chalyan T, Ottevaere H, Pasquardini L (2024) Optical biosensors: From working principles to detection methods of label-free devices. Biophotonics and Biosensing. Elsevier p 15\u201348","DOI":"10.1016\/B978-0-44-318840-4.00009-7"},{"issue":"1","key":"8068_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/bios15010035","volume":"15","author":"MA Butt","year":"2025","unstructured":"Butt MA (2025) Surface plasmon resonance-based biodetection systems: principles, progress and applications\u2014a comprehensive review. Biosensors 15(1):35","journal-title":"Biosensors"},{"key":"8068_CR99","doi-asserted-by":"crossref","unstructured":"Kumari A, Yadav A, Singh O, Sharan P (2024) A review of surface plasmon resonance (SPR) technology in biosensing: innovations, applications and future trends. J Optics 1\u20139","DOI":"10.1007\/s12596-024-02265-3"},{"issue":"10","key":"8068_CR100","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/bios11100402","volume":"11","author":"SHS Mandala","year":"2021","unstructured":"Mandala SHS, Liu T-J, Chen C-M, Liu K-K, Januar M, Chang Y-F et al (2021) Enhanced plasmonic biosensor utilizing paired antibody and label-free Fe3O4 nanoparticles for highly sensitive and selective detection of Parkinson\u2019s \u03b1-synuclein in serum. Biosensors 11(10):402","journal-title":"Biosensors"},{"issue":"9","key":"8068_CR101","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00604-020-04507-0","volume":"187","author":"Z Yin","year":"2020","unstructured":"Yin Z, Cheng X, Wang G, Chen J, Jin Y, Tu Q et al (2020) SPR immunosensor combined with Ti4+@ TiP nanoparticles for the evaluation of phosphorylated alpha-synuclein level. Microchim Acta 187(9):509","journal-title":"Microchim Acta"},{"issue":"10","key":"8068_CR102","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00604-022-05465-5","volume":"189","author":"X Hu","year":"2022","unstructured":"Hu X, Hu R, Zhu H, Chen Q, Lu Y, Chen J et al (2022) Nanozyme-based cascade SPR signal amplification for immunosensing of nitrated alpha-synuclein. Microchim Acta 189(10):367","journal-title":"Microchim Acta"},{"issue":"34","key":"8068_CR103","doi-asserted-by":"publisher","DOI":"10.1002\/admi.202300354","volume":"10","author":"Z Liu","year":"2023","unstructured":"Liu Z, Guo T, Tan Q, Fan H, He S (2023) Guided mode induced surface phase mutation for enhanced SPR biosensor with dual\u2010parameters interrogation. Adv Mater Interfaces 10(34):2300354","journal-title":"Adv Mater Interfaces"},{"issue":"1","key":"8068_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1917","volume":"16","author":"AK Dhillon","year":"2024","unstructured":"Dhillon AK, Sharma A, Yadav V, Singh R, Ahuja T, Barman S et al (2024) Raman spectroscopy and its plasmon-enhanced counterparts: a toolbox to probe protein dynamics and aggregation. Wiley Interdiscip Rev Nanomed Nanobiotechnol 16(1):e1917","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"1","key":"8068_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30010015","volume":"30","author":"H Lai","year":"2024","unstructured":"Lai H, Wang X, Qi M, Huang H, Yu B (2024) Advances in surface-enhanced raman spectroscopy for therapeutic drug monitoring. Molecules 30(1):15","journal-title":"Molecules"},{"key":"8068_CR106","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.bios.2014.10.049","volume":"67","author":"JH An","year":"2015","unstructured":"An JH, Choi D-K, Lee K-J, Choi J-W (2015) Surface-enhanced raman spectroscopy detection of dopamine by DNA targeting amplification assay in Parkisons\u2019s model. Biosens Bioelectron 67:739\u2013746","journal-title":"Biosens Bioelectron"},{"issue":"8","key":"8068_CR107","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1039\/D3AN00027C","volume":"148","author":"I Badillo-Ram\u00edrez","year":"2023","unstructured":"Badillo-Ram\u00edrez I, Landeros-Rivera B, Saniger JM, Popp J, Cialla-May D (2023) Sers-based detection of 5-S-cysteinyl-dopamine as a novel biomarker of Parkinson\u2019s disease in artificial biofluids. Analyst 148(8):1848\u20131857","journal-title":"Analyst"},{"key":"8068_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2023.342036","volume":"1285","author":"JO Park","year":"2024","unstructured":"Park JO, Choi Y, Ahn HM, Lee CK, Chun H, Park YM et al (2024) Aggregation of Ag nanoparticle based on surface acoustic wave for surface-enhanced Raman spectroscopy detection of dopamine. Anal Chim Acta 1285:342036","journal-title":"Anal Chim Acta"},{"key":"8068_CR109","doi-asserted-by":"crossref","unstructured":"Choi J-H, Kim T-H, El-Said WA, Lee J-H, Yang L, Conley B et al. (2020) In situ detection of neurotransmitters from stem cell-derived neural interface at the single-cell level via graphene-hybrid SERS nanobiosensing. Nano Lett 20(10):7670\u20139","DOI":"10.1021\/acs.nanolett.0c03205"},{"issue":"18","key":"8068_CR110","doi-asserted-by":"publisher","first-page":"15388","DOI":"10.1021\/acsami.8b01063","volume":"10","author":"K Zhang","year":"2018","unstructured":"Zhang K, Liu Y, Wang Y, Zhang R, Liu J, Wei J et al (2018) Quantitative SERS detection of dopamine in cerebrospinal fluid by dual-recognition-induced hot spot generation. ACS Appl Mater Interfaces 10(18):15388\u201315394","journal-title":"ACS Appl Mater Interfaces"},{"key":"8068_CR111","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bios.2015.04.013","volume":"71","author":"L Tang","year":"2015","unstructured":"Tang L, Li S, Han F, Liu L, Xu L, Ma W et al (2015) SERS-active Au@ Ag nanorod dimers for ultrasensitive dopamine detection. Biosens Bioelectron 71:7\u201312","journal-title":"Biosens Bioelectron"},{"issue":"5","key":"8068_CR112","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1166\/jnn.2011.3688","volume":"11","author":"J-H An","year":"2011","unstructured":"An J-H, El-Said WA, Yea C-H, Kim T-H, Choi J-W (2011) Surface-enhanced raman scattering of dopamine on self-assembled gold nanoparticles. J Nanosci Nanotechnol 11(5):4424\u20134429","journal-title":"J Nanosci Nanotechnol"},{"issue":"5","key":"8068_CR113","doi-asserted-by":"publisher","DOI":"10.1007\/s00604-022-05292-8","volume":"189","author":"A Zhu","year":"2022","unstructured":"Zhu A, Wang T, Jiang Y, Hu S, Tang W, Liu X et al (2022) SERS determination of dopamine using metal\u2013organic frameworks decorated with Ag\/Au noble metal nanoparticle composite after azo derivatization with p-aminothiophenol. Microchimica Acta 189(5):207","journal-title":"Microchimica Acta"},{"issue":"21","key":"8068_CR114","doi-asserted-by":"publisher","first-page":"12158","DOI":"10.1039\/D1CP00966D","volume":"23","author":"I Badillo-Ram\u00edrez","year":"2021","unstructured":"Badillo-Ram\u00edrez I, Saniger JM, Popp J, Cialla-May D (2021) SERS characterization of dopamine and in situ dopamine polymerization on silver nanoparticles. Phys Chem Chem Phys 23(21):12158\u201312170","journal-title":"Phys Chem Chem Phys"},{"issue":"2","key":"8068_CR115","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1021\/acssensors.3c02202","volume":"9","author":"Y Gwon","year":"2024","unstructured":"Gwon Y, Kim J-H, Lee S-W (2024) Quantification of plasma dopamine in depressed patients using silver-enriched silicon nanowires as SERS-active substrates. ACS Sensors 9(2):870\u201382","journal-title":"ACS Sensors"},{"key":"8068_CR116","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.colsurfb.2014.12.028","volume":"126","author":"L Qin","year":"2015","unstructured":"Qin L, Li X, Kang S-Z, Mu J (2015) Gold nanoparticles conjugated dopamine as sensing platform for SERS detection. Colloids Surf B Biointerfaces 126:210\u2013216","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"4","key":"8068_CR117","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410395","volume":"12","author":"T Li","year":"2025","unstructured":"Li T, Wang Qa, Cao Z, Zhu J, Wang N, Li R et al (2025) Nerve\u2010inspired optical waveguide stretchable sensor fusing wireless transmission and AI enabling smart tele\u2010healthcare. Adv Sci 12(4):2410395","journal-title":"Adv Sci"},{"issue":"8","key":"8068_CR118","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1364\/BOE.398013","volume":"11","author":"V Mittal","year":"2020","unstructured":"Mittal V, Devitt G, Nedeljkovic M, Carpenter LG, Chong HM, Wilkinson JS et al (2020) Ge on Si waveguide mid-infrared absorption spectroscopy of proteins and their aggregates. Biomed Opt Express 11(8):4714\u20134722","journal-title":"Biomed Opt Express"},{"key":"8068_CR119","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mri.2021.07.002","volume":"83","author":"JR Hadley","year":"2021","unstructured":"Hadley JR, Odeen H, Merrill R, Adams S, Rieke V, Payne A et al (2021) Improving image quality in transcranial magnetic resonance guided focused ultrasound using a conductive screen. Magnet Res Imaging 83:41\u20139","journal-title":"Magnet Res Imaging"},{"issue":"2","key":"8068_CR120","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12551-020-00679-4","volume":"12","author":"WE Arter","year":"2020","unstructured":"Arter WE, Levin A, Krainer G, Knowles TP (2020) Microfluidic approaches for the analysis of protein\u2013protein interactions in solution. Biophys Rev 12(2):575\u2013585","journal-title":"Biophys Rev"},{"key":"8068_CR121","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.snb.2018.06.123","volume":"273","author":"Z Liu","year":"2018","unstructured":"Liu Z, Jin M, Cao J, Niu R, Li P, Zhou G et al (2018) Electrochemical sensor integrated microfluidic device for sensitive and simultaneous quantification of dopamine and 5-hydroxytryptamine. Sens Actuators B: Chem 273:873\u2013883","journal-title":"Sens Actuators B: Chem"},{"key":"8068_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbsr.2019.100270","volume":"23","author":"A Manbohi","year":"2019","unstructured":"Manbohi A, Ahmadi SH (2019) Sensitive and selective detection of dopamine using electrochemical microfluidic paper-based analytical nanosensor. Sens Bio-Sens Res 23:100270","journal-title":"Sens Bio-Sens Res"},{"issue":"3","key":"8068_CR123","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3340\/jkns.2015.57.3.152","volume":"57","author":"MS Heo","year":"2015","unstructured":"Heo MS, Moon HS, Kim HC, Park HW, Lim YH, Paek SH (2015) Fully implantable deep brain stimulation system with wireless power transmission for long-term use in rodent models of parkinson\u2019s disease. J Korean Neurosurg Soc 57(3):152\u2013158","journal-title":"J Korean Neurosurg Soc"},{"key":"8068_CR124","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2021.01.023","volume":"84","author":"F Sasaki","year":"2021","unstructured":"Sasaki F, Oyama G, Sekimoto S, Nuermaimaiti M, Iwamuro H, Shimo Y et al (2021) Closed-loop programming using external responses for deep brain stimulation in Parkinson\u2019s disease. Park Relat Disord 84:47\u201351","journal-title":"Park Relat Disord"},{"issue":"9","key":"8068_CR125","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41587-021-00897-5","volume":"39","author":"G Re","year":"2021","unstructured":"Re G, Little S, Perrone R, Wilt R, de Hemptinne C, Yaroshinsky MS et al (2021) Long-term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson\u2019s disease. Nat Biotechnol 39(9):1078\u20131085","journal-title":"Nat Biotechnol"},{"issue":"2","key":"8068_CR126","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3171\/2016.11.JNS161162","volume":"128","author":"NC Swann","year":"2017","unstructured":"Swann NC, De Hemptinne C, Miocinovic S, Qasim S, Ostrem JL, Galifianakis NB et al (2017) Chronic multisite brain recordings from a totally implantable bidirectional neural interface: experience in 5 patients with Parkinson\u2019s disease. J Neurosurg 128(2):605\u2013616","journal-title":"J Neurosurg"},{"key":"8068_CR127","doi-asserted-by":"crossref","unstructured":"Rojas E, Schmidt SL, Chowdhury A, Pajic M, Turner DA, Won DS (2022) A comparison of an implanted accelerometer with a wearable accelerometer for closed-loop DBS. 2022 44th annual international conference of the IEEE engineering in Medicine & Biology Society (EMBC): IEEE p 3439\u201342","DOI":"10.1109\/EMBC48229.2022.9871232"},{"issue":"5","key":"8068_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00415-025-13085-1","volume":"272","author":"Y Ma","year":"2025","unstructured":"Ma Y, Zhang Y, Li R, Cheng W, Wu F (2025) The experience and perception of wearable devices in Parkinson\u2019s disease patients: a systematic review and meta-synthesis of qualitative studies. J Neurol 272(5):1\u201318","journal-title":"J Neurol"},{"issue":"1","key":"8068_CR129","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41531-025-00953-w","volume":"11","author":"W-S Lim","year":"2025","unstructured":"Lim W-S, Fan S-P, Chiu S-I, Wu M-C, Wang P-H, Lin K-P et al (2025) Smartphone-derived multidomain features including voice, finger-tapping movement and gait aid early identification of Parkinson\u2019s disease. npj Parkinson\u2019s Disease 11(1):111","journal-title":"npj Parkinson\u2019s Disease"},{"issue":"7","key":"8068_CR130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0327733","volume":"20","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, Wu E, Leng P, Sun J, Ma M, Pan Z (2025) Finger drawing on smartphone screens enables early Parkinson\u2019s disease detection through hybrid 1D-CNN and BiGRU deep learning architecture. PLoS ONE 20(7):e0327733","journal-title":"PLoS ONE"},{"key":"8068_CR131","doi-asserted-by":"crossref","unstructured":"Ymeri G, Maus B, Wassenburg M, Olsson CM, Svenningsson P, Salvi D (2024) Usability of a mobile application for patients with Parkinson\u2019s Disease. 2024 46th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC): IEEE p 1\u20136","DOI":"10.1109\/EMBC53108.2024.10782276"},{"issue":"7","key":"8068_CR132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236258","volume":"15","author":"M Juutinen","year":"2020","unstructured":"Juutinen M, Wang C, Zhu J, Haladjian J, Ruokolainen J, Puustinen J et al (2020) Parkinson\u2019s disease detection from 20-step walking tests using inertial sensors of a smartphone: Machine learning approach based on an observational case-control study. PLoS ONE 15(7):e0236258","journal-title":"PLoS ONE"},{"issue":"8","key":"8068_CR133","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s13204-018-0863-0","volume":"8","author":"V Saxena","year":"2018","unstructured":"Saxena V, Chandra P, Pandey LM (2018) Design and characterization of novel Al-doped ZnO nanoassembly as an effective nanoantibiotic. Appl Nanosci 8(8):1925\u20131941","journal-title":"Appl Nanosci"},{"key":"8068_CR134","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.bios.2013.03.025","volume":"47","author":"B Agrawal","year":"2013","unstructured":"Agrawal B, Chandra P, Goyal RN, Shim Y-B (2013) Detection of norfloxacin and monitoring its effect on caffeine catabolism in urine samples. Biosens Bioelectron 47:307\u2013312","journal-title":"Biosens Bioelectron"},{"key":"8068_CR135","doi-asserted-by":"crossref","unstructured":"Kumar A, Purohit B, Mahato K, Chandra P (2019) Advance engineered nanomaterials in point-of-care immunosensing for biomedical diagnostics","DOI":"10.1039\/9781788016162-00238"},{"issue":"44","key":"8068_CR136","doi-asserted-by":"publisher","first-page":"39586","DOI":"10.1021\/acsomega.2c05414","volume":"7","author":"P Ratre","year":"2022","unstructured":"Ratre P, Jain B, Kumari R, Thareja S, Tiwari R, Srivastava RK et al (2022) Bioanalytical applications of graphene quantum dots for circulating cell-free nucleic acids: a review. ACS omega 7(44):39586\u2013602","journal-title":"ACS omega"},{"issue":"2","key":"8068_CR137","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/bios13020226","volume":"13","author":"P Ratre","year":"2023","unstructured":"Ratre P, Nazeer N, Kumari R, Thareja S, Jain B, Tiwari R et al (2023) Carbon-based fluorescent nano-biosensors for the detection of cell-free circulating MicroRNAs. Biosensors 13(2):226","journal-title":"Biosensors"},{"issue":"8","key":"8068_CR138","doi-asserted-by":"publisher","DOI":"10.1002\/elan.202200355","volume":"35","author":"V Ranjan Srivastava","year":"2023","unstructured":"Ranjan Srivastava V, Kumari R, Chandra P (2023) Miniaturized surface engineered technologies for multiplex biosensing devices. Electroanalysis 35(8):e202200355","journal-title":"Electroanalysis"},{"issue":"8","key":"8068_CR139","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ultramic.2009.03.012","volume":"109","author":"KR Lee","year":"2009","unstructured":"Lee KR, Kang I-J (2009) Effects of dopamine concentration on energy transfer between dendrimer\u2013QD and dye-labeled antibody. Ultramicroscopy 109(8):894\u2013898","journal-title":"Ultramicroscopy"},{"issue":"1","key":"8068_CR140","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/srep01537","volume":"3","author":"W Ma","year":"2013","unstructured":"Ma W, Qin L-X, Liu F-T, Gu Z, Wang J, Pan ZG et al (2013) Ubiquinone-quantum dot bioconjugates for in vitro and intracellular complex I sensing. Sci Rep 3(1):1537","journal-title":"Sci Rep"},{"key":"8068_CR141","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.bios.2016.09.022","volume":"87","author":"D Diaz-Diestra","year":"2017","unstructured":"Diaz-Diestra D, Thapa B, Beltran-Huarac J, Weiner BR, Morell G (2017) L-cysteine capped ZnS: Mn quantum dots for room-temperature detection of dopamine with high sensitivity and selectivity. Biosens Bioelectron 87:693\u2013700","journal-title":"Biosens Bioelectron"},{"issue":"23","key":"8068_CR142","doi-asserted-by":"publisher","first-page":"8102","DOI":"10.1021\/ja900225w","volume":"131","author":"MJ Roberti","year":"2009","unstructured":"Roberti MJ, Morgan M, Menendez G, Pietrasanta LI, Jovin TM, Jares-Erijman EA (2009) Quantum dots as ultrasensitive nanoactuators and sensors of amyloid aggregation in live cells. J Am Chem Soc 131(23):8102\u20138107","journal-title":"J Am Chem Soc"},{"issue":"23","key":"8068_CR143","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1007\/s00216-020-02787-2","volume":"412","author":"K Abha","year":"2020","unstructured":"Abha K, Sumithra I, Suji S, Anjana R, Anjali Devi J, Nebu J et al (2020) Dopamine-induced photoluminescence quenching of bovine serum albumin\u2013capped manganese-doped zinc sulphide quantum dots. Anal Bioanal Chem 412(23):5671\u20135681","journal-title":"Anal Bioanal Chem"},{"issue":"49","key":"8068_CR144","doi-asserted-by":"publisher","first-page":"17223","DOI":"10.1021\/acs.analchem.2c03926","volume":"94","author":"S Tang","year":"2022","unstructured":"Tang S, Wu X, Zhao P, Tang K, Chen Y, Fu J et al (2022) Ratiometric fluorescence capillary sensor-integrated molecular imprinting for simultaneous detection of two biological indicators of Parkinson\u2019s disease. Anal Chem 94(49):17223\u201317231","journal-title":"Anal Chem"},{"issue":"1","key":"8068_CR145","doi-asserted-by":"publisher","first-page":"9981628","DOI":"10.1155\/jamc\/9981628","volume":"2025","author":"L Yin","year":"2025","unstructured":"Yin L, Du Y, Ge M, Zhang X, Du X, Wu X (2025) Rod-shaped NanoZnTPyP paper-based sensor for visual detection of dopamine in human plasma. J Anal Methods Chem 2025(1):9981628","journal-title":"J Anal Methods Chem"},{"issue":"2","key":"8068_CR146","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/nano14020170","volume":"14","author":"GM Di Mari","year":"2024","unstructured":"Di Mari GM, Scuderi M, Lanza G, Salluzzo MG, Salemi M, Caraci F et al (2024) Pain-free Alpha-Synuclein detection by low-cost hierarchical nanowire based electrode. Nanomaterials 14(2):170","journal-title":"Nanomaterials"},{"key":"8068_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2024.342559","volume":"1304","author":"JF Giarola","year":"2024","unstructured":"Giarola JF, Santos J, Estevez M-C, Ventura S, Pallares I, Lechuga LM (2024) An \u03b1-helical peptide-based plasmonic biosensor for highly specific detection of \u03b1-synuclein toxic oligomers. Anal Chim Acta 1304:342559","journal-title":"Anal Chim Acta"},{"key":"8068_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2025.161329","volume":"509","author":"S Jeong","year":"2025","unstructured":"Jeong S, Park S-H, Lee S, Cho H, Lee K-y, Ju BK et al (2025) Electrochemical biosensor based on gold nanoparticles\/laser induced graphene for diagnosis of Parkinson\u2019s disease by detecting phosphorylated \u03b1-synuclein in human blood. Chem Eng J 509:161329","journal-title":"Chem Eng J"},{"issue":"1","key":"8068_CR149","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5012\/bkcs.2014.35.1.25","volume":"35","author":"J-W Lim","year":"2014","unstructured":"Lim J-W, Kang I-J (2014) Fabrication of chitosan-gold nanocomposites combined with optical fiber as SERS substrates to detect dopamine molecules. Bull Korean Chem Soc 35(1):25\u201329","journal-title":"Bull Korean Chem Soc"},{"issue":"2","key":"8068_CR150","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1039\/C8AN01279B","volume":"144","author":"MNS Karabo\u011fa","year":"2019","unstructured":"Karabo\u011fa MNS, Sezgint\u00fcrk MK (2019) Cerebrospinal fluid levels of alpha-synuclein measured using a poly-glutamic acid-modified gold nanoparticle-doped disposable neuro-biosensor system. Analyst 144(2):611\u2013621","journal-title":"Analyst"},{"issue":"4","key":"8068_CR151","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1021\/acschemneuro.7b00439","volume":"9","author":"Y Liu","year":"2017","unstructured":"Liu Y, Xu L-P, Wang Q, Yang B, Zhang X (2017) Synergistic inhibitory effect of GQDs\u2013tramiprosate covalent binding on amyloid aggregation. ACS Chem Neurosci 9(4):817\u2013823","journal-title":"ACS Chem Neurosci"},{"key":"8068_CR152","doi-asserted-by":"crossref","unstructured":"Mohammadi S, Nikkhah M, Hosseinkhani S (2017) Investigation of the effects of carbon-based nanomaterials on A53T alpha-synuclein aggregation using a whole-cell recombinant biosensor. Int J Nanomed 8831\u201340","DOI":"10.2147\/IJN.S144764"},{"issue":"9","key":"8068_CR153","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41565-018-0179-y","volume":"13","author":"D Kim","year":"2018","unstructured":"Kim D, Yoo JM, Hwang H, Lee J, Lee SH, Yun SP et al (2018) Graphene quantum dots prevent \u03b1-synucleinopathy in Parkinson\u2019s disease. Nat Nanotechnol 13(9):812\u2013818","journal-title":"Nat Nanotechnol"},{"issue":"50","key":"8068_CR154","doi-asserted-by":"publisher","first-page":"15283","DOI":"10.1021\/acs.langmuir.8b02674","volume":"34","author":"DK Ban","year":"2018","unstructured":"Ban DK, Somu P, Paul S (2018) Graphene oxide quantum dot alters amyloidogenicity of hen egg white lysozyme via modulation of protein surface character. Langmuir 34(50):15283\u201315292","journal-title":"Langmuir"},{"issue":"5","key":"8068_CR155","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00216-018-1534-4","volume":"411","author":"H Ahmadi","year":"2019","unstructured":"Ahmadi H, Faridbod F, Mehrzad-Samarin M (2019) Entacapone detection by a GOQDs-molecularly imprinted silica fluorescent chemical nanosensor. Anal Bioanal Chem 411(5):1075\u20131084","journal-title":"Anal Bioanal Chem"},{"issue":"37","key":"8068_CR156","doi-asserted-by":"publisher","first-page":"19450","DOI":"10.1039\/D0NR05003B","volume":"12","author":"M Ghaeidamini","year":"2020","unstructured":"Ghaeidamini M, Bernson D, Sasanian N, Kumar R, Esbj\u00f6rner EK (2020) Graphene oxide sheets and quantum dots inhibit \u03b1-synuclein amyloid formation by different mechanisms. Nanoscale 12(37):19450\u201319460","journal-title":"Nanoscale"},{"key":"8068_CR157","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.toxlet.2022.05.006","volume":"363","author":"S Deng","year":"2022","unstructured":"Deng S, Zhang E, Wang Y, Zhao Y, Yang Z, Zheng B et al (2022) In vivo toxicity assessment of four types of graphene quantum dots (GQDs) using mRNA sequencing. Toxicol Lett 363:55\u201366","journal-title":"Toxicol Lett"},{"issue":"10","key":"8068_CR158","doi-asserted-by":"publisher","DOI":"10.1007\/s00604-022-05479-z","volume":"189","author":"K Wang","year":"2022","unstructured":"Wang K, Li Y, Qi M, Li C, Dong B, Xu L et al (2022) Screening of dopamine in living cells and animal model via graphene quantum dots anchored 3D macroporous nonenzymatic sensor. Microchim Acta 189(10):382","journal-title":"Microchim Acta"},{"key":"8068_CR159","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2022.102608","volume":"47","author":"P Kaliyaperumal","year":"2023","unstructured":"Kaliyaperumal P, Renganathan S, Arumugam K, Aremu BR (2023) Engineered graphene quantum dot nanocomposite triggers \u03b1-synuclein defibrillation: therapeutics against Parkinson\u2019s disease. Nanomed Nanotechnol Biol Med 47:102608","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"8068_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2024.342237","volume":"1292","author":"NTN Anh","year":"2024","unstructured":"Anh NTN, Huynh TV, Nguyen TKA, Doong R-a (2024) MXene nanosheet-derived N, S-codoped graphene quantum dots for ultrasensitive and selective detection of 3-nitro-l-tyrosine in human serum. Anal Chim Acta 1292:342237","journal-title":"Anal Chim Acta"},{"key":"8068_CR161","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jcis.2024.04.111","volume":"667","author":"X Wu","year":"2024","unstructured":"Wu X, Wang G, Zhao Z, Qian Z (2024) In silico study on graphene quantum dots modified with various functional groups inhibiting \u03b1\u2011synuclein dimerization. J Colloid Interface Sci 667:723\u2013730","journal-title":"J Colloid Interface Sci"},{"issue":"20","key":"8068_CR162","doi-asserted-by":"publisher","first-page":"e202400629","DOI":"10.1002\/asia.202400629","volume":"19","author":"S Biswas","year":"2024","unstructured":"Biswas S, Chowdhury T, Banerjee S, Dutta K, Das AK, Das D (2024) Improving the Efficiency of Luminescent Zn (II)-Modified N-Doped GOQD Nanomaterials in Parkinson\u2019s Disease Treatment: A Theoretical Mechanistic Framework Exploring Doping Effect. Chem-Asian J. 19(20):e202400629","journal-title":"Chem-Asian J."},{"issue":"4","key":"8068_CR163","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1039\/C8AN02171F","volume":"144","author":"R Nandi","year":"2019","unstructured":"Nandi R, Loitongbam L, De J, Jain V, Pal SK (2019) Gold nanoparticle-mediated signal amplification of liquid crystal biosensors for dopamine. Analyst 144(4):1110\u20131114","journal-title":"Analyst"},{"issue":"20","key":"8068_CR164","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s11434-016-1172-1","volume":"61","author":"X Ren","year":"2016","unstructured":"Ren X, Ge J, Meng X, Qiu X, Ren J, Tang F (2016) Sensitive detection of dopamine and quinone drugs based on the quenching of the fluorescence of carbon dots. Sci Bull 61(20):1615\u20131623","journal-title":"Sci Bull"},{"key":"8068_CR165","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2022.128330","volume":"638","author":"L Wu","year":"2022","unstructured":"Wu L, Pan W, Ye H, Liang N, Zhao L (2022) Sensitive fluorescence detection for hydrogen peroxide and glucose using biomass carbon dots: dual-quenching mechanism insight. Colloids Surf A Physicochem Eng Asp 638:128330","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"8068_CR166","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.bios.2016.10.033","volume":"89","author":"SH Qaddare","year":"2017","unstructured":"Qaddare SH, Salimi A (2017) Amplified fluorescent sensing of DNA using luminescent carbon dots and AuNPs\/GO as a sensing platform: a novel coupling of FRET and DNA hybridization for homogeneous HIV-1 gene detection at femtomolar level. Biosens Bioelectron 89:773\u2013780","journal-title":"Biosens Bioelectron"},{"issue":"1","key":"8068_CR167","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010190","volume":"23","author":"T-H Le","year":"2021","unstructured":"Le T-H, Kim J-H, Park S-J (2021) Turn on\u201d fluorescence sensor of glutathione based on inner filter effect of co-doped carbon dot\/gold nanoparticle composites. Int J Mol Sci 23(1):190","journal-title":"Int J Mol Sci"}],"container-title":["Microchimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00604-026-08068-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00604-026-08068-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00604-026-08068-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:02:05Z","timestamp":1781071325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00604-026-08068-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":167,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["8068"],"URL":"https:\/\/doi.org\/10.1007\/s00604-026-08068-6","relation":{},"ISSN":["0026-3672","1436-5073"],"issn-type":[{"value":"0026-3672","type":"print"},{"value":"1436-5073","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"371"}}